If you read this space, you probably know the name Brad Bushman. He studies the effects of violent video games on the people who play them. He also has just retracted his third paper, and significantly corrected another. Although Bushman remains a prominent voice in a highly contentious field — prompting numerous media to consult … Continue reading Prominent video game-violence researcher loses another paper to retraction
Less than two weeks ago, PLOS ONE published a paper about the parents of teenagers who appeared to immediately start questioning their gender identity around the time of puberty. Then the critiques flooded in. The paper — about a highly contentious issue — surveyed parents who felt that their children had suddenly started to question … Continue reading Reader outcry prompts Brown to retract press release on trans teens
Late last year, news stories trumpeted the findings: Older women who received surgery to fix their cataracts were less likely to die over the course of a study period. Now, the same group of authors is saying the exact opposite may be true. Last week, the researchers retracted their 2017 paper in JAMA Ophthalmology and … Continue reading A high-profile paper linked cataract surgery to a lower risk of death. It was wrong.
A researcher who was found guilty of committing misconduct while using three federal grants has published new findings that cites those grants. In 2012, the U.S. Office of Research Integrity determined that Michael Miller, a former department chair at the State University of New York (SUNY) Upstate Medical University in Syracuse, had committed misconduct by … Continue reading Researcher found to have committed misconduct using federal grants is publishing again — and cites those very grants
Last year, an academic society recommended that journals retract nine papers by a researcher in Japan who collaborated with a notorious fraudster. Only two have been retracted. The researcher is Yuhji Saitoh of Yachiyo Medical Center and Tokyo Women’s Medical University, who co-authored many papers with Yoshitaka Fujii, an anethesiologist who holds the dubious distinction … Continue reading A year ago, an academic society recommended nine papers be retracted. Journals have retracted only two.
Here’s something we haven’t seen before: The U.S. Office of Research Integrity has issued a second notice for a former researcher at the National Institutes of Health, after determining she withheld information during the first investigation. Last year, the ORI sanctioned Brandi M. Baughman — formerly at the National Institute of Environmental and Health Sciences … Continue reading In what appears to be a first, researcher sanctioned twice by ORI
Last year, the soil science community was rocked by reports that an editor, Artemi Cerdà, was accused of citation stacking — asking authors to cite particular papers — boosting his profile, and that of journals where he worked. (Cerdà has denied the allegations.) The case had some major fallout: Cerdà resigned from two journals and … Continue reading Can soil science research dig itself out from a citation stacking scandal?
Paul Brookes is a biologist with a passion for sleuthing out fraud. Although he studies mitochondria at the University of Rochester, he also secretly ran a science-fraud.org, a site for people to post their concerns about papers. Following legal threats, he revealed he was the author and shut the site in 2013 — but didn’t … Continue reading What if we could scan for image duplication the way we check for plagiarism?
Since the U.S. government launched a database of freely available journal articles in 2000, it has deselected roughly only 30 titles over concerns about journal quality. Fourteen of those titles were removed last August, all associated with one publisher — Kowsar. According to a spokesperson for the National Library of Medicine (NLM), which manages the … Continue reading In unusual move, gov’t database delists 14 journals from one publisher
Many journals are adopting a recently developed mechanism for correcting the scientific record known as “retract and replace” — usually employed when the original paper has been affected by honest errors. But if an article is retracted and replaced, can readers always tell? To find out, Ana Marušić at the University of Split School of … Continue reading A new publishing approach — retract and replace — is having growing pains
How much role did a potentially problematic paper play in the demise of a once-promising compound? Researchers are questioning the validity of a high-profile article, published by Nature in 2006. Although the letter is 12 years old, the concerns have current implications: It was among the early evidence used to develop a cancer compound that … Continue reading Figures in cancer paper at root of newly failed compound called into question
Following a massive editorial protest, Scientific Reports is admitting its handling of a disputed paper was “insufficient and inadequate,” and has agreed to retract it. The 2016 paper was initially corrected by the journal, after a researcher at Johns Hopkins University, Michael Beer, accused it of lifting some of his earlier work. After we covered … Continue reading Over a dozen editorial board members resigned when a journal refused to retract a paper. Today, it’s retracted.
An external probe has concluded that a researcher based at the University of Gothenburg committed misconduct in multiple papers, all of which should be withdrawn. Among 10 papers by Suchitra Sumitran-Holgersson at the University of Gothenburg, an Expert Group concluded that eight contained signs of scientific misconduct. The Expert Group, part of Sweden’s Central Ethical … Continue reading Probe finds misconduct in eight papers by researcher in Sweden
A former researcher at New York University falsified and/or fabricated data in multiple papers and grant applications, according to the U.S. Office of Research Integrity. Bhagavathi Narayanan has already retracted three papers, the result of missing original data. Among the three papers flagged by the ORI, only one remains intact: A 2011 paper in Anticancer … Continue reading Former NYU researcher falsified data in 3 papers, 7 grants: ORI
After being “blindsided” a few months ago when she was told one of her 2005 papers was going to be retracted, a researcher scrambled to get information about why. And when she didn’t like the answers, she took to PubPeer. Eight days ago, Shalon (Babbitt) Ledbetter, the first author of the 2005 paper published in … Continue reading Delays, arguing over upcoming Cell retraction leave first author “devastated”
Retractions take too long, carry too much of a stigma, and often provide too little information about what went wrong. Many people agree there’s a problem, but often can’t concur on how to address it. In one attempt, a group of experts — including our co-founder Ivan Oransky — convened at Stanford University in December … Continue reading The retraction process needs work. Is there a better way?
A journal is retracting a paper after it discovered researchers gave a child the wrong supplement for more than a year. Rhiannon Bugno, managing editor for Biological Psychiatry, told Retraction Watch the mix-up did not put the patient at risk. However, the mistake was enough for the journal’s editor, John Krystal, of Yale University, to … Continue reading Child took wrong compound for over a year after “communication error”
Nowadays, there are many ways to access a paper — on the publisher’s website, on MEDLINE, PubMed, Web of Science, Scopus, and other outlets. So when the publisher retracts a paper, do these outlets consistently mark it as such? And if they don’t, what’s the impact? Researchers Caitlin Bakker and Amy Riegelman at the University of Minnesota … Continue reading Want to tell if a paper has been retracted? Good luck
Shocked, confused, disappointed — these are the reactions of authors who recently published in a cancer journal that was delisted by a company that indexes journals. Recently, Clarivate Analytics announced it would discontinue indexing Oncotarget after the first few issues of 2018 — as a result, the journal would not receive a current impact factor. The company … Continue reading When a journal is delisted, authors pay a price
An independent analysis of how The Ohio State University reviewed allegations of misconduct against a high-profile cancer researcher has found that the institution “complied with applicable law and with relevant institutional policies and reached reasoned and supportable conclusions.” The review follows numerous allegations of research misconduct against Carlo Croce, described in a March 8 story … Continue reading Probe into Carlo Croce reached “defensible and reasonable” decis…